How many patents does
Lycera Corporation have?
patents
227
families
25
granted
46
applications
181
US
59
EP
42
WO
32
JP
19
CN
9
KR
2
RoW
64
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Lycera Corporation
Top ten assignees appearing on patents
2009 - 2018
| lycera corporation | 195 |
| merck & company | 39 |
2009
2018
| lycera corporation | 33 |
| merck & company | 1 |
Lycera Corporation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 31 | 2010 |
| tetrahydronaphthyridine and related bicyclic compounds for inhibition of rorgamma activi… 🛈 | 18 | 2012 |
| pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 17 | 2010 |
| bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of dise… 🛈 | 16 | 2012 |
| trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 16 | 2013 |
| tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ro… 🛈 | 15 | 2012 |
| tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and th… 🛈 | 11 | 2014 |
| n-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 10 | 2013 |
| n- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory a… 🛈 | 9 | 2010 |
| adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan rece… 🛈 | 9 | 2014 |